LogoFDA 510(k) Search
Search Filters

Search Results

Found 1 results

510(k) Data Aggregation

    K Number
    K012742
    Device Name
    TEETHMATE F-1
    Manufacturer
    KURARAY MEDICAL INC.
    Date Cleared
    2001-09-14

    (31 days)

    Product Code
    EBC
    Regulation Number
    872.3765
    Type
    Traditional
    Panel
    Dental
    Reference & Predicate Devices
    K965091
    Predicate For
    N/A
    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    TEETHMATE F-1 is indicated for the following application: 1) Pit and fissure sealant

    Device Description

    This product is classified into the pit and fissure sealant and conditioner, CFR 21 Section 872.3765, because it is a device composed of resin, such as polymethyl methacrylate, intended for use primary in young children to seal pit and fissure depressions in the biting surfaces of teeth to present cavities.

    AI/ML Overview

    There is insufficient information within the provided text to describe acceptance criteria and a study proving a device meets these criteria. The document is a 510(k) summary for a dental material (TEETHMATE F-1), which primarily addresses its substantial equivalence to a predicate device for marketing purposes. It does not contain details about performance acceptance criteria or specific studies to demonstrate compliance.

    The document discusses:

    • Device Identification: TEETHMATE F-1, a pit and fissure sealant.
    • Submission Purpose: To change the name and address of the manufacturer (Kuraray Co., Ltd. transferring business to Kuraray Medical Inc.).
    • Predicate Device: TEETHMATE F-1 by Kuraray Co., Ltd. (K965091).
    • Intended Use: Pit and fissure sealant.
    • Technological Characteristics and Safety: Stated as "completely the same" as the predicate device.
    • FDA Correspondence: Notification of substantial equivalence determination.

    None of these sections detail performance metrics, acceptance criteria, or specific study designs (like sample sizes, expert qualifications, adjudication methods, or MRMC studies) related to the device's performance. The FDA's letter merely confirms the substantial equivalence determination based on the provided information, not necessarily on new performance studies.

    Ask a Question

    Ask a specific question about this device

    Page 1 of 1